{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T13:30:05Z","timestamp":1769347805009,"version":"3.49.0"},"reference-count":9,"publisher":"Societas Neurologica Japonica","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5692\/clinicalneurol.52.399","type":"journal-article","created":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T18:07:01Z","timestamp":1340734021000},"page":"399-404","source":"Crossref","is-referenced-by-count":3,"title":["Genetic diagnosis and molecular pathology of inherited neuropathy"],"prefix":"10.5692","volume":"52","author":[{"given":"Hiroshi","family":"Takashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"3) Boerkoel CF, Takashima H, Garcia CA, et al. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 2002;51:190-201.","DOI":"10.1002\/ana.10089"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1385\/NMM:8:1:243"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22166"},{"key":"4","doi-asserted-by":"crossref","unstructured":"6) Abe A, Numakura C, Kijima K, et al. Molecular diagnosis and clinical onset of Charcot-Marie-Tooth disease in Japan. J Hum Genet 2011;56:364-368.","DOI":"10.1038\/jhg.2011.20"},{"key":"5","doi-asserted-by":"crossref","unstructured":"8) Passage E, Norreel JC, Noack-Fraissignes P, et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 2004;10:396-401.","DOI":"10.1038\/nm1023"},{"key":"6","doi-asserted-by":"crossref","unstructured":"9) Pareyson D, Reilly MM, Schenone A, et al. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol 2011;10:320-328.","DOI":"10.1016\/S1474-4422(11)70025-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"10) Burns J, Joseph PD, Rose KJ, et al. Effect of oral curcumin on D&eacute;j&eacute;rine-Sottas disease. Ped iatr Neurol 2009;41:305-308.","DOI":"10.1016\/j.pediatrneurol.2009.04.030"},{"key":"8","doi-asserted-by":"crossref","unstructured":"12) d'Ydewalle C, Krishnan J, Chiheb DM, et al. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat Med 2011;17:968-974.","DOI":"10.1038\/nm.2396"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908094"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u907a\u4f1d\u6027\u30cb\u30e5\u30fc\u30ed\u30d1\u30c1\u30fc\u306e\u8a3a\u65ad\u3068\u5206\u5b50\u75c5\u614b"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T20:04:44Z","timestamp":1621541084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/52\/6\/52_399\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.52.399","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}